Keywords:
Lung, Oncology, Thorax, CT, CT-High Resolution, Radiation therapy / Oncology, Abscess, Cancer, Lymphoma
Authors:
C. Valdesi1, S. Conte1, L. Fabrizio2, M. Scutti3, L. Mazzamurro4, M. Mereu1, R. L. Patea1, A. R. Cotroneo1; 1chieti/IT, 2San Salvo/IT, 3Guardiagrele/IT, 4pescara/IT
DOI:
10.26044/esti2019/P-0097
Background
The development of pulmonary metastases in patients with known malignancies indicates disseminated disease and places the patient in end stage disease.
This typically implies an adverse prognosis and imaging studies plays an important role in the screening and detection of pulmonary metastases,
to improve clinical management.
Computed tomography (CT) is the first imaging modality in detecting pulmonary metastases.
Most frequently,
the classic appearance of hematogenous metastases or lymphangitic carcinomatosis and clinical history of malignant disease allow confident diagnosis.
Sometimes,
however,
metastatic spread presents atypical radiologic findings and may simulate other conditions such asfungal infections,
septic emboli,
tuberculosis,
sarcoidosis,
Wegener granulomatosis and rheumatoid nodules.
It is mandatory to make the correct diagnosis to correlate CT findings with the clinical context and laboratory tests.